AJANTA PHARMA
Back to Income Statement
|
AJANTA PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹816 Cr | ₹588 Cr | ₹713 Cr | ₹654 Cr | ₹468 Cr |
What is the latest Consolidated Net Profit of AJANTA PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹816 Cr |
| Mar2024 | ₹588 Cr |
| Mar2023 | ₹713 Cr |
| Mar2022 | ₹654 Cr |
| Mar2021 | ₹468 Cr |
How is Consolidated Net Profit of AJANTA PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹816 Cr | 38.81 | |
| Mar2024 | ₹588 Cr | -17.50 | |
| Mar2023 | ₹713 Cr | 8.99 | |
| Mar2022 | ₹654 Cr | 39.81 | |
| Mar2021 | ₹468 Cr | - | |
Compare Consolidated Net Profit of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹35,961.8 Cr | 6.9% | -2% | 6.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,559.0 Cr | 7.1% | -1.5% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,827.0 Cr | 2.8% | -2.8% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,942.0 Cr | 3.1% | 4.2% | 18.8% | Stock Analytics | |
| CIPLA | ₹106,825.0 Cr | 0.2% | -12.5% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,077.0 Cr | 2.2% | -1.6% | 0% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 6.9% |
-2% |
6.1% |
| SENSEX | 1.7% |
-1.7% |
10.3% |
You may also like the below Video Courses